Sarepta Therapeutics Stock Price - SRPT

123.23
1.33 (1.09%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Sarepta Therapeutics Inc New SRPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.88 -0.72% 121.90 121.41 124.52 123.00 122.78 20:00:00
Bid Price Ask Price Spread Spread % News
118.00 123.30 5.30 4.3% - 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,015 487,655 $ 122.71 $ 59,841,696 861,715 72.05 - 158.80
Last Trade Time Type Quantity Stock Price Currency
19:03:24 5 $ 123.23 USD

Sarepta Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 9.09B 74.54M $ -361.92M -5.45 - 59.13M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sarepta Therapeutics News

Loading Messages....

Latest SRPT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRPT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week124.94127.30121.41124.60493,240-3.04-2.43%
1 Month121.80127.30108.545118.82717,3260.100.08%
3 Months108.51145.0099.8341124.521,147,87713.3912.34%
6 Months125.44145.0072.05102.791,404,089-3.54-2.82%
1 Year137.60158.8072.05115.621,302,791-15.70-11.41%
3 Years28.88176.5028.0882.831,538,22693.02322.09%
5 Years14.6001176.508.0052.472,029,879107.30734.93%

Sarepta Therapeutics Description

Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.